214 related articles for article (PubMed ID: 35240921)
1. High-Risk Injection-Related Practices Associated with anti-HCV Positivity among Young Adults Seeking Services in Three Small Cities in Wisconsin.
Rogers-Brown J; Sublett F; Canary L; Rein DB; Bhat M; Thompson WW; Vellozzi C; Asher A
Subst Use Misuse; 2022; 57(5):665-673. PubMed ID: 35240921
[TBL] [Abstract][Full Text] [Related]
2. High prevalence of HIV, HBsAg and anti-HCV positivity among people who injected drugs: results of the first bio-behavioral survey using respondent-driven sampling in two urban areas in Mozambique.
Semá Baltazar C; Horth R; Boothe M; Sathane I; Young P; Chitsondzo Langa D; Condula M; Ricardo H; Dengo Baloi L; Cummings B; Schaad N; Gouveia L; Teodoro E; Raymond HF
BMC Infect Dis; 2019 Dec; 19(1):1022. PubMed ID: 31791273
[TBL] [Abstract][Full Text] [Related]
3. Epidemiology of HIV and hepatitis C infection among women who inject drugs in Northeast India: a respondent-driven sampling study.
McFall AM; Solomon SS; Lucas GM; Celentano DD; Srikrishnan AK; Kumar MS; Mehta SH
Addiction; 2017 Aug; 112(8):1480-1487. PubMed ID: 28317210
[TBL] [Abstract][Full Text] [Related]
4. Drug use stigma and its association with active hepatitis C virus infection and injection drug use behaviors among community-based people who inject drugs in India.
Patel EU; Solomon SS; Lucas GM; McFall AM; Tomori C; Srikrishnan AK; Kumar MS; Laeyendecker O; Celentano DD; Thomas DL; Quinn TC; Mehta SH
Int J Drug Policy; 2021 Oct; 96():103354. PubMed ID: 34247900
[TBL] [Abstract][Full Text] [Related]
5. Prevalence and risk factors associated with HIV/hepatitis B and HIV/hepatitis C co-infections among people who inject drugs in Mozambique.
Semá Baltazar C; Boothe M; Kellogg T; Ricardo P; Sathane I; Fazito E; Raymond HF; Temmerman M; Luchters S
BMC Public Health; 2020 Jun; 20(1):851. PubMed ID: 32493347
[TBL] [Abstract][Full Text] [Related]
6. High variability of HIV and HCV seroprevalence and risk behaviours among people who inject drugs: results from a cross-sectional study using respondent-driven sampling in eight German cities (2011-14).
Wenz B; Nielsen S; Gassowski M; Santos-Hövener C; Cai W; Ross RS; Bock CT; Ratsch BA; Kücherer C; Bannert N; Bremer V; Hamouda O; Marcus U; Zimmermann R;
BMC Public Health; 2016 Sep; 16(1):927. PubMed ID: 27595567
[TBL] [Abstract][Full Text] [Related]
7. Prevalence of hepatitis C virus in young people who inject drugs in four Colombian cities: A cross-sectional study using Respondent Driven Sampling.
Toro-Tobón D; Berbesi-Fernandez D; Mateu-Gelabert P; Segura-Cardona ÁM; Montoya-Vélez LP
Int J Drug Policy; 2018 Oct; 60():56-64. PubMed ID: 30107313
[TBL] [Abstract][Full Text] [Related]
8. Age-Related Differences in Past or Present Hepatitis C Virus Infection Among People Who Inject Drugs: National Human Immunodeficiency Virus Behavioral Surveillance, 8 US Cities, 2015.
Abara WE; Trujillo L; Broz D; Finlayson T; Teshale E; Paz-Bailey G; Glick S; Al-Tayyib AA; Robinson WT; Masiello-Schuette S; Sey EK; Anderson BJ; Poe J; Braunstein S
J Infect Dis; 2019 Jul; 220(3):377-385. PubMed ID: 30915477
[TBL] [Abstract][Full Text] [Related]
9. Prevalence of HIV/Hepatitis C Virus Co-Infection and Injection Risk Correlations in People Who Inject Drugs in Colombia: A Cross-Sectional Study Using Respondent Driven Sampling.
Toro-Tobón D; Berbesi-Fernández D
Subst Use Misuse; 2020; 55(3):414-423. PubMed ID: 31691646
[No Abstract] [Full Text] [Related]
10. Risky injection practices and HCV awareness in Chiang Mai Province, Thailand: a respondent-driven sampling study of people who inject drugs.
Prouté M; Le Coeur S; Tiv MH; Dub T; Jongpaijitsakul P; Ratnamhin A; Angkurawaranon C; Aramrattana A; Lallemant M
BMC Public Health; 2020 Sep; 20(1):1450. PubMed ID: 32972359
[TBL] [Abstract][Full Text] [Related]
11. Understanding hepatitis B, hepatitis C and HIV among people who inject drugs in South Africa: findings from a three-city cross-sectional survey.
Scheibe A; Young K; Moses L; Basson RL; Versfeld A; Spearman CW; Sonderup MW; Prabdial-Sing N; Manamela J; Puren AJ; Rebe K; Hausler H
Harm Reduct J; 2019 Apr; 16(1):28. PubMed ID: 30975139
[TBL] [Abstract][Full Text] [Related]
12. HCV serostatus and injection sharing practices among those who obtain syringes from pharmacies and directly and indirectly from syringe services programs in rural New England.
Romo E; Rudolph AE; Stopka TJ; Wang B; Jesdale BM; Friedmann PD
Addict Sci Clin Pract; 2023 Jan; 18(1):2. PubMed ID: 36597153
[TBL] [Abstract][Full Text] [Related]
13. Investigating the sociodemographic and behavioural factors associated with hepatitis C virus testing amongst people who inject drugs in England, Wales and Northern Ireland: A quantitative cross-sectional analysis.
Yuan JM; Croxford S; Viviani L; Emanuel E; Phipps E; Desai M
Int J Drug Policy; 2022 Nov; 109():103821. PubMed ID: 35994940
[TBL] [Abstract][Full Text] [Related]
14. Hepatitis C virus prevalence, determinants, and cascade of care among people who inject drugs in Iran.
Khezri M; Mirzazadeh A; Shokoohi M; Sharafi H; Ghalekhani N; Tavakoli F; Mehmandoost S; Mousavian G; Imani M; Kakavand-Ghalehnoei R; Komasi A; Gouya MM; Haghdoost AA; McFarland W; Karamouzian M; Sharifi H
Drug Alcohol Depend; 2023 Feb; 243():109751. PubMed ID: 36621200
[TBL] [Abstract][Full Text] [Related]
15. Correlates of anti-hepatitis C positivity and use of harm reduction services among people who inject drugs in two cities in Croatia.
Handanagic S; Sevic S; Barbaric J; Dominkovic Z; Dakovic Rode O; Begovac J; Bozicevic I
Drug Alcohol Depend; 2017 Feb; 171():132-139. PubMed ID: 28088084
[TBL] [Abstract][Full Text] [Related]
16. Cross-border injection drug use and HIV and hepatitis C virus seropositivity among people who inject drugs in San Diego, California.
Horyniak D; Wagner KD; Armenta RF; Cuevas-Mota J; Hendrickson E; Garfein RS
Int J Drug Policy; 2017 Sep; 47():9-17. PubMed ID: 28683432
[TBL] [Abstract][Full Text] [Related]
17. Hepatitis C antibody prevalence, correlates and barriers to care among people who inject drugs in Central California.
Ozga JE; Syvertsen JL; Pollini RA
J Viral Hepat; 2022 Jul; 29(7):518-528. PubMed ID: 35357738
[TBL] [Abstract][Full Text] [Related]
18. Baseline prevalence and correlates of HIV and HCV infection among people who inject drugs accessing a syringe services program; Miami, FL.
Bartholomew TS; Onugha J; Bullock C; Scaramutti C; Patel H; Forrest DW; Feaster DJ; Tookes HE
Harm Reduct J; 2020 Jun; 17(1):40. PubMed ID: 32522201
[TBL] [Abstract][Full Text] [Related]
19. Association of spatial proximity to fixed-site syringe services programs with HCV serostatus and injection equipment sharing practices among people who inject drugs in rural New England, United States.
Romo E; Stopka TJ; Jesdale BM; Wang B; Mazor KM; Friedmann PD
Harm Reduct J; 2024 Jan; 21(1):23. PubMed ID: 38282000
[TBL] [Abstract][Full Text] [Related]
20. Young people who inject drugs in India have high HIV incidence and behavioural risk: a cross-sectional study.
Ganapathi L; McFall AM; Srikrishnan AK; Kumar MS; Anand S; Lucas GM; Mehta SH; Harris SK; Solomon SS
J Int AIDS Soc; 2019 May; 22(5):e25287. PubMed ID: 31116005
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
